The company provides consultation services in the area of innonative drug development to pharmaceutical companies, biotech companies and other parties active in that field.

The specific expertise of Sirius Scientific Consulting lays in the development of drug candidates with pharmacological effects in brain, in the spinal cord, in the retina of the eye, and other nervous tissues of the human body. The disease areas covered are neurological, psychiatric and other diseases caused by neuronal deficits. A specific focus of Sirius Scientific Consulting is neurodegenerative diseases of the brain, e.g. Parkinson`s disease and Alzheimer`s disease, and of the retina, e.g. glaucoma and macular degeneration.

The consultation services offered by Sirius Scientific Consulting include the scientific evaluation of drug development projects, strategic advice for licensing opportunities, guiding drug development activities, coaching of pharma professionals, evaluation of alternative development options, review of drug project portfolios, and scientific support of fund raising.

In addition, Sirius Scientific Consulting offers creation of documents required for the drug development process, like clinical study protocols, clinical development plans, overall development plans, target product profiles, regulatory strategy concepts and others.